Enhertu plus pertuzumab approved in the EU for the 1st-line treatment of patients with HER2-positive...

SYS6010 granted BTD by the NMPA in China for the treatment of patients with recurrent...

Hansoh Pharmaceutical’s HS-20093 injection marketing authorization application for SCLC accepted by China’s NMPA

IDEAYA Biosciences’ IDE849 advances to a phase 3 registrational trial following a successful FDA type...

DualityBio enters global collaboration with Roche to develop next-generation ADCs using the DUPAC novel-payload platform

HUTCHMED announces licensing agreement with GSK for KRAS-EGFR antibody conjugate cancer therapy